about
Early detection of cardiac dysfunction in the type 1 diabetic heart using speckle-tracking based strain imaging.Diabetes mellitus reduces the function and expression of ATP-dependent K⁺ channels in cardiac mitochondriaContribution of electromechanical coupling between Kv and Ca v1.2 channels to coronary dysfunction in obesity.Contribution of BK(Ca) channels to local metabolic coronary vasodilation: Effects of metabolic syndrome.Restoration of coronary endothelial function in obese Zucker rats by a low-carbohydrate diet.Effects of anion channel antagonists in canine colonic myocytes: comparative pharmacology of Cl-, Ca2+ and K+ currents.The pure anti-oestrogen ICI 182,780 (Faslodex) activates large conductance Ca(2+)-activated K(+) channels in smooth muscle.Chronic and selective inhibition of basolateral membrane Na-K-ATPase uniquely regulates brush border membrane Na absorption in intestinal epithelial cells.Diphenyl phosphine oxide-1-sensitive K(+) channels contribute to the vascular tone and reactivity of resistance arteries from brain and skeletal muscle.Penitrem A as a tool for understanding the role of large conductance Ca(2+)/voltage-sensitive K(+) channels in vascular function.Interactions between A(2A) adenosine receptors, hydrogen peroxide, and KATP channels in coronary reactive hyperemiaKV7 channels contribute to paracrine, but not metabolic or ischemic, regulation of coronary vascular reactivity in swineAdenosine A1 receptors link to smooth muscle contraction via CYP4a, protein kinase C-α, and ERK1/2Impaired function of coronary BK(Ca) channels in metabolic syndromeBisphenol A activates BK channels through effects on α and β1 subunits.Phosphatidylinositol 3-kinase inhibitors reveal a unique mechanism of enhancing insulin secretion in 832/13 rat insulinoma cells.Contribution of voltage-dependent K+ and Ca2+ channels to coronary pressure-flow autoregulation.Voltage-dependent K+ channels regulate the duration of reactive hyperemia in the canine coronary circulation.Ethylbromide tamoxifen, a membrane-impermeant antiestrogen, activates smooth muscle calcium-activated large-conductance potassium channels from the extracellular side.C-reactive protein does not relax vascular smooth muscle: effects mediated by sodium azide in commercially available preparations.Reduced molecular expression of K(+) channel proteins in vascular smooth muscle from rats made hypertensive with N{omega}-nitro-L-arginine.Dynamic Regulation of the Subunit Composition of BK Channels in Smooth Muscle.Reduced functional expression of K(+) channels in vascular smooth muscle cells from rats made hypertensive with N{omega}-nitro-L-arginine.Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction.Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome.Adenosine A1 receptors in neointimal hyperplasia and in-stent stenosis in Ossabaw miniature swine.Redox-dependent coronary metabolic dilation.Small-conductance Ca(2+)-dependent K+ channels activated by ATP in murine colonic smooth muscle.H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscleKnockout Mice Reveal That the Angiotensin II type 1B Receptor Links to Smooth Muscle ContractionCoronary Vasomotor Reactivity to Endothelin-1 in the Prediabetic Metabolic SyndromeH2O2-induced redox-sensitive coronary vasodilation is mediated by 4-aminopyridine-sensitive K+ channelsHydrogen PeroxideResistin impairs endothelium-dependent dilation to bradykinin, but not acetylcholine, in the coronary circulation
P50
Q28384879-e583b8a9-4c2a-07b3-9377-5e843c9587afQ28395463-898eb081-408f-f9f5-0498-c25464ede99fQ30556993-F916EDC5-AECB-48F8-AA69-55BF26C286CDQ33727584-3F9024E6-6B4C-45A4-B99D-A364F8D0D20DQ34601284-02C52BA7-9E25-4CFD-9A08-BD37A8712766Q35029227-ab9beee1-496f-5f8c-630f-b3d6a48af6cdQ35044494-EFE06A8C-F28D-478E-BA53-E1C3FC85B0B2Q35437188-6a196d9a-4ff7-d044-dd76-3af3cffdcb02Q35547545-bc18a9b7-460b-6959-6526-9a43e7001c78Q36105407-778289ec-4fbd-4c36-a070-6f21d50c30bcQ36837892-efb132f3-41da-58de-1e1c-5f8f8836bebfQ36895771-f78b07a8-4de8-0964-0c9e-18280aa924bbQ37008916-64da573b-4b9c-7998-6020-c1f591e5152bQ37430986-2620F916-FACF-476A-A02B-0922500772A8Q39029227-9d199571-48fc-3383-50af-5ef46285e3b4Q40504342-5D4DF3E7-05A9-42DF-9AE6-0C9222C16D4AQ41887785-3f10c9e7-437b-3848-0af5-a597e7c0a1aeQ42650403-7DA6B38C-FA8E-4D97-9205-E4503E9BBC9BQ42674571-FC3C362B-EFB1-4753-8F5D-9DC289192E64Q45162556-CFCAEC07-CB4D-45CA-92E0-049B60A6EF88Q46406336-B50E4FBE-B184-44FC-B5D6-53F89D84966EQ46417477-3f9b4569-4f37-4753-0058-eb23c4ba1d12Q46477766-1CF4C8AC-54B2-4E56-822E-C6364F25940BQ46491184-6C3EA063-A76F-4400-8E84-148AD9943C26Q46662826-BB09AF7F-8476-4365-BD17-7A48D872537FQ46747898-B029704A-4DB7-4EAC-A6B1-6772EE6C31A1Q46927645-8AD9C3A0-E1CB-434C-80FB-34EC95D76FB8Q53960899-cce304da-4b97-71ed-d869-7c914b80ccb0Q62000262-63C93E6F-7A75-42B3-B062-EEA2A3ED8090Q62000264-C4D6517F-49FA-4AF6-AEF7-E00DF846063AQ62000267-8FC8600F-E7C5-43A7-9B7A-697FD4738B33Q62000269-76422FAA-EC2B-46C0-AB94-CE0E6608DFF7Q62000272-751A4BAD-4E6B-437D-94FA-510E131ADAA7Q62000273-C2C2E89E-C067-40F7-98AB-4D019F1ED3B7
P50
description
medical researcher
@en
onderzoeker
@nl
name
Gregory M. Dick
@ast
Gregory M. Dick
@en
Gregory M. Dick
@es
Gregory M. Dick
@nl
Gregory M. Dick
@sl
type
label
Gregory M. Dick
@ast
Gregory M. Dick
@en
Gregory M. Dick
@es
Gregory M. Dick
@nl
Gregory M. Dick
@sl
altLabel
Gregory M Dick
@en
prefLabel
Gregory M. Dick
@ast
Gregory M. Dick
@en
Gregory M. Dick
@es
Gregory M. Dick
@nl
Gregory M. Dick
@sl
P1053
G-3032-2010
P106
P1153
7102551366
P1960
WyIvMc0AAAAJ
P21
P31
P3829
P496
0000-0003-1444-6436